Literature DB >> 6896429

Tissue distribution and anti-inflammatory activity of corticosteroids incorporated in lipid emulsion.

Y Mizushima, T Hamano, K Yokoyama.   

Abstract

Dexamethasone palmitate was incorporated into a lipid emulsion (Intralipid, Intralipos) and was injected into rats, and its distribution in the organs and tissues and its anti-inflammatory effects were compared with those of free dexamethasone disodium phosphate. The distribution patterns of [3H] dexamethasone were markedly different between the 2 preparations in 3 hours after intravenous administration. Dexamethasone palmitate given as a lipid emulsion showed a much higher concentration in the blood, spleen, and inflamed tissues (carrageenan oedema), whereas dexamethasone sodium phosphate had a high concentration in the muscles. The anti-inflammatory activity of both preparations given intravenously was evaluated by using the preformed carrageenan granuloma pouch method. The anti-inflammatory activity of lipid emulsion dexamethasone was 5.6 times as potent as an equivalent amount of free dexamethasone. These results may indicate that corticosteroids which are incorporated in lipid emulsions are taken up by the reticuloendothelial system and some inflammatory cells much more than are free corticosteroids; thus they have a stronger anti-inflammatory activity. The clinical use of lipid emulsion corticosteroids for certain types of diseases is suggested.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6896429      PMCID: PMC1000924          DOI: 10.1136/ard.41.3.263

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  6 in total

1.  Liposome-incorporated corticosteroids. II. Therapeutic activity in experimental arthritis.

Authors:  N C Phillips; D P Thomas; C G Knight; J T Dingle
Journal:  Ann Rheum Dis       Date:  1979-12       Impact factor: 19.103

2.  Liposomes in arthritis: a new approach.

Authors:  M de Silva; B L Hazleman; D P Thomas; P Wraight
Journal:  Lancet       Date:  1979-06-23       Impact factor: 79.321

3.  Liposomes as drug carriers.

Authors:  J H Fendler; A Romero
Journal:  Life Sci       Date:  1977-04-01       Impact factor: 5.037

4.  Hepatic "intravenous fat pigment" in infants and children receiving lipid emulsion.

Authors:  Y Koga; V L Swanson; D M Hays
Journal:  J Pediatr Surg       Date:  1975-10       Impact factor: 2.545

5.  Liposome-incorporated corticosteroids: I. The interaction of liposomal cortisol palmitate with inflammatory synovial membrane.

Authors:  I H Shaw; C G Knight; D P Thomas; N C Phillips; J T Dingle
Journal:  Br J Exp Pathol       Date:  1979-04

6.  Diminished bacterial defences with intralipid.

Authors:  G W Fischer; K W Hunter; S R Wilson; A D Mease
Journal:  Lancet       Date:  1980-10-18       Impact factor: 79.321

  6 in total
  16 in total

1.  Preparation, characterization, pharmacokinetics and tissue distribution of solid lipid nanoparticles loaded with tetrandrine.

Authors:  Su Li; Zhaoshuai Ji; Meijuan Zou; Xin Nie; Yijie Shi; Gang Cheng
Journal:  AAPS PharmSciTech       Date:  2011-08-03       Impact factor: 3.246

2.  Liposteroid therapy for juvenile and adult dermatomyositis: efficacy and side effects.

Authors:  Hiroyuki Wakiguchi
Journal:  Ann Transl Med       Date:  2017-03

Review 3.  Cell-mediated drug delivery.

Authors:  Elena V Batrakova; Howard E Gendelman; Alexander V Kabanov
Journal:  Expert Opin Drug Deliv       Date:  2011-02-24       Impact factor: 6.648

4.  Entrapping efficiency and drug release profile of an oil-in-water (o/w) emulsion formulation using a polydimethylsiloxane-coated glass bead assay.

Authors:  T Minagawa; Y Kohno; T Suwa; A Tsuji
Journal:  Pharm Res       Date:  1994-04       Impact factor: 4.200

5.  Targeting steroid therapy in rheumatoid arthritis.

Authors:  Y Mizushima; K Kaneko; K Hoshi
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

6.  Aneurysmal dilatation of ductus arteriosus during lipo-prostaglandin E1 therapy for diaphragmatic hernia.

Authors:  M Tohyama; A Baba; T Tsuno; K Aonuma; A Komiyama
Journal:  Eur J Pediatr       Date:  1993-11       Impact factor: 3.183

7.  Enhancement of tissue delivery and receptor occupancy of methylprednisolone in rats by a liposomal formulation.

Authors:  E V Mishina; R M Straubinger; N A Pyszczynski; W J Jusko
Journal:  Pharm Res       Date:  1993-10       Impact factor: 4.200

8.  Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins.

Authors:  Natalia L Klyachko; Matthew J Haney; Yuling Zhao; Devika S Manickam; Vivek Mahajan; Poornima Suresh; Shawn D Hingtgen; R Lee Mosley; Howard E Gendelman; Alexander V Kabanov; Elena V Batrakova
Journal:  Nanomedicine (Lond)       Date:  2013-11-18       Impact factor: 5.307

9.  Nanoparticles containing anti-inflammatory agents as chemotherapy adjuvants: optimization and in vitro characterization.

Authors:  Xiuling Lu; Melissa D Howard; Marta Mazik; Joshua Eldridge; John J Rinehart; Michael Jay; Markos Leggas
Journal:  AAPS J       Date:  2008-03-04       Impact factor: 4.009

10.  Liposteroid against refractory pulmonary haemorrhage in idiopathic pulmonary haemosiderosis.

Authors:  S Ohga; A Nomura; N Suga; S Hikino; R Kira; A Matsuzaki; K Masuda; K Ueda
Journal:  Eur J Pediatr       Date:  1994-09       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.